FDA NDC Directory · JSON-LD · Markdown

Paclitaxel protein-bound particles

NDC 69097-398 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

Labeler / ManufacturerCipla USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA209657
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · INTRAVENOUS
Active ingredientsPACLITAXEL (100 mg/20mL)
Marketing started20250415
Package count1

External sources

Source: openFDA. Public-domain (CC0).